NCT04972565View on ClinicalTrials.gov

Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

March 21, 2025

Study Completion Date

March 21, 2025

Conditions
Hypermobile EDS (hEDS)Hypermobility Syndrome
Interventions
BEHAVIORAL

Usual Care plus Inspiratory Muscle Training (IMT)

Participants will receive usual care and will also be provided with a personalized prescription for an IMT program for 8 weeks. Participants will perform two daily IMT sessions of 30 breaths (\< 5 minutes/session), 5 days per week in their home environment. IMT intensity will be progressed weekly by 5-10% of the baseline maximal inspiratory pressure if the Borg Dyspnea score is \< 7.

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT04972565 - Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder | Biotech Hunter | Biotech Hunter